Results 11 to 20 of about 38,005 (190)
The synergistic anti-leishmanial effect of photodynamic therapy employing chemotherapy-mediated nanocomposites [PDF]
Scientific ReportsCutaneous leishmaniasis (CL) presents a significant therapeutic challenge due to limitations of current treatments like meglumine antimoniate (MAT), including drug resistance and adverse side effects. Photodynamic therapy (PDT) has emerged as a promising,
Elahe Molaakbari +7 more
doaj +2 more sources
Co‐endemicity of schistosomiasis and tegumentary leishmaniasis: Spatial co‐clustering in endemic areas [PDF]
Tropical Medicine &International Health, Volume 30, Issue 6, Page 556-568, June 2025.Abstract Objectives Schistosomiasis and tegumentary leishmaniasis simultaneously affect areas in tropical and subtropical regions. Co‐infected individuals show a less‐than‐optimal response to treatment and increased regulatory immune responses. However, no study has determined where Schistosoma–Leishmania co‐infections are more likely to occur ...
Genil Mororó Araújo Camelo +6 more
wiley +2 more sources
Spiny Hyperkeratosis-Like Follicular Mycosis Fungoides: A Case Report [PDF]
Middle East Journal of Cancer, 2023 Folliculotropic mycosis fungoides (FMF) is a rare variant of cutaneous T-cell lymphoma which is categorized as a separate entity. In histopathology, malignant lymphocytes selectively surround and infiltrate hair follicles.
Shatila Torabi +3 more
doaj +1 more source
Evaluation of clinical risk factors for systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to dermatology clinics of Mashhad University of Medical Sciences, Iran [PDF]
Journal of Kerman University of Medical Sciences, 2023 Background: Systemic or topical form of pentavalent antimony compounds such as Meglumine Antimoniate (MA) are used as Standard treatment for cutaneous leishmaniasis (CL).
Yalda Nahidi +5 more
doaj +1 more source
Interspecies and Intrastrain Interplay among Leishmania spp. Parasites
Microorganisms, 2022 Leishmania parasites present astonishing adaptative abilities that represent a matter of life or death within disparate environments during the heteroxenous parasite life cycle.
Bruna Dias das Chagas +6 more
doaj +1 more source
Leishmania (Viannia) naiffi Lainson & Shaw 1989
Parasites & Vectors, 2023 Just over 30 years ago, a new species of Leishmania of the subgenus Leishmania (Viannia) was described infecting the armadillo Dasypus novemcinctus; then, a report of human infection followed.
Lilian Motta Cantanhêde +1 more
doaj +1 more source
Frontiers in Microbiology, 2021 Cutaneous leishmaniasis (CL) is a curable disease; however, due to various risk factors, unresponsiveness to CL treatments is inevitable. The treatment of CL has been firmly correlated with multiple determinants, such as demographical, clinical, and ...
Mehdi Bamorovat +4 more
doaj +1 more source
Microorganisms, 2023 A relevant aspect in the epidemiology of Tegumentary Leishmaniasis (TL) are the Leishmania parasites carrying a viral endosymbiont, Leishmania RNA Virus 1 (LRV1), a dsRNA virus.
Mayara Cristhine de Oliveira Santana +3 more
doaj +1 more source
Clinical Case Reports, 2021 Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long‐term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.
Maryam Mahdavi +4 more
doaj +1 more source
Gates Open Research, 2019 Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj +1 more source